ConductScience.org, home

Paper21994752

Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?

Nasr R and 5 others. Viruses, 2011. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects? Papers, record 21994752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21994752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
PubMed
Journal
Viruses
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2021-10-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nasr RRihab
2El Hajj HHiba
3Kfoury YYoumna
4de Thé HHugues
5Hermine OOlivier
6Bazarbachi AAli

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Human T-lymphotropic virus 1Major topic
Leukemia-Lymphoma, Adult T-CellMajor topic
Animals
Antiviral Agents
Drug Therapy, Combination
Gene Products, tax
Humans
Mice
Virus Replication

Source PubMed

Download CSV of topics

References111

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112613513Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.Leuk Lymphoma2002https://conductscience.org/library/papers/12613513PubMed
29864171Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.Blood1999https://conductscience.org/library/papers/9864171PubMed
39694868NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation.J Biol Chem1998https://conductscience.org/library/papers/9694868PubMed
418376405Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.Nat Med2008https://conductscience.org/library/papers/18376405PubMed
519270265HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.Blood2009https://conductscience.org/library/papers/19270265PubMed
616540180The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).Antiviral Res2006https://conductscience.org/library/papers/16540180PubMed
71751370Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).Br J Haematol1991https://conductscience.org/library/papers/1751370PubMed
820940416The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.Blood2011https://conductscience.org/library/papers/20940416PubMed
919411628Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).Blood2009https://conductscience.org/library/papers/19411628PubMed
1015522654New therapeutic approaches for adult T-cell leukaemia.Lancet Oncol2004https://conductscience.org/library/papers/15522654PubMed
1110899027The immune response to HTLV-I.Curr Opin Immunol2000https://conductscience.org/library/papers/10899027PubMed
129152417AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.J Gen Virol1997https://conductscience.org/library/papers/9152417PubMed
132871307HTLV-I associated myelopathy, a new clinical entity.Lancet1986https://conductscience.org/library/papers/2871307PubMed
1420585095Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.J Clin Oncol2010https://conductscience.org/library/papers/20585095PubMed
1521347344HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.PLoS Pathog2011https://conductscience.org/library/papers/21347344PubMed
167579327Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection.Blood1995https://conductscience.org/library/papers/7579327PubMed
179808547Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.Blood1998https://conductscience.org/library/papers/9808547PubMed
1815048063Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.Hematol J2004https://conductscience.org/library/papers/15048063PubMed
197760890Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.N Engl J Med1995https://conductscience.org/library/papers/7760890PubMed
2021135137Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.J Exp Med2010https://conductscience.org/library/papers/21135137PubMed

See all 111 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42648572Modeling of ex vivo immune response reveals a central role for CD8+CD25+ cells in Adult T-cell Leukemia survival: a long-term prospective cohort study.Tumour Virus Res2026https://conductscience.org/library/papers/42648572PubMed
37834255Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets.Int J Mol Sci2023https://conductscience.org/library/papers/37834255PubMed
37689806Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.Med Oncol2023https://conductscience.org/library/papers/37689806PubMed
35935975Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.Front Immunol2022https://conductscience.org/library/papers/35935975PubMed
35464257Molecular fusion events in carcinogenic organisms: a bioinformatics study for the detection of fused proteins between viruses, bacteria and eukaryotes.EMBnet J2022https://conductscience.org/library/papers/35464257PubMed
34735653Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.Curr Oncol Rep2021https://conductscience.org/library/papers/34735653PubMed
33471856In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ.PLoS Pathog2021https://conductscience.org/library/papers/33471856PubMed
32636814Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma.Front Microbiol2020https://conductscience.org/library/papers/32636814PubMed
32369988Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview.Pathogens2020https://conductscience.org/library/papers/32369988PubMed
31103249Molecular biology of human T cell leukemia virus.Semin Diagn Pathol2020https://conductscience.org/library/papers/31103249PubMed
30657736Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.J Clin Oncol2019https://conductscience.org/library/papers/30657736PubMed
29593659How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.Front Microbiol2018https://conductscience.org/library/papers/29593659PubMed
29296718Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α.Blood Adv2017https://conductscience.org/library/papers/29296718PubMed
27110706Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.Virology2016https://conductscience.org/library/papers/27110706PubMed
26690203Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases.Viruses2015https://conductscience.org/library/papers/26690203PubMed
25699089Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer.Infect Agent Cancer2014https://conductscience.org/library/papers/25699089PubMed
25436765Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors.Pathogens2012https://conductscience.org/library/papers/25436765PubMed
24470863Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers.Iran J Basic Med Sci2013https://conductscience.org/library/papers/24470863PubMed
23962110The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.Retrovirology2013https://conductscience.org/library/papers/23962110PubMed
23943384Therapeutic options for adult T-cell leukemia/lymphoma.Curr Oncol Rep2013https://conductscience.org/library/papers/23943384PubMed

See all 22 cited byDownload CSV of cited by

Genes22

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CENPV201161PubTator's text mininghttps://conductscience.org/library/genes/201161NCBI Gene
CNTN26900PubTator's text mininghttps://conductscience.org/library/genes/6900NCBI Gene
CREB11385PubTator's text mininghttps://conductscience.org/library/genes/1385NCBI Gene
HBZ3050PubTator's text mininghttps://conductscience.org/library/genes/3050NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene
NRP18829PubTator's text mininghttps://conductscience.org/library/genes/8829NCBI Gene
POLB5423PubTator's text mininghttps://conductscience.org/library/genes/5423NCBI Gene
PRAM184106PubTator's text mininghttps://conductscience.org/library/genes/84106NCBI Gene
SOCS18651PubTator's text mininghttps://conductscience.org/library/genes/8651NCBI Gene
SPI16688PubTator's text mininghttps://conductscience.org/library/genes/6688NCBI Gene
SRF6722PubTator's text mininghttps://conductscience.org/library/genes/6722NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

See all 22 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21994752

GET https://conductscience.org/api/papers/v1/21994752/references?page=2